Amiloride for peak identification (Y0001902)


Product Details

CAT No.# CS-EG-00074
Category EP Standards
CAS 17440-83-4
Molecular Weight 302.12
Molecular Formula C6H8ClN7OHCl2H2O
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Amiloride impurity A (Y0000020)
5. 7-Aminodesacetoxycephalosporanic acid (A0460000)
6. Aminoglutethimide impurity A (A0496005)
7. Aminoglutethimide impurity D (A0496020)
8. Amiodarone impurity D (Y0000129)
9. Amiodarone impurity E (Y0000130)
10. Amisulpride for system suitability (Y0001534)
11. Amlodipine besilate (Y0000049)
12. Amlodipine impurity A (Y0001068)
13. Amlodipine impurity B (Y0001069)
14. Amlodipine impurity G (Y0001070)
15. Amlodipine for peak identification (Y0001067)
16. Abacavir Related Compound A (F1L311)
17. L-Alanyl-L-Glutamine (F004H0)
18. rAlbumin Human (R04600)
19. Albuterol Sulfate (K0G284)
20. Albuterol Related Compound B (F0M123)

This page contains information about Amiloride for peak identification (Y0001902) Cas 17440-83-4 and its EP Standards.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."